Systematic review of erythropoiesis-stimulating agent dosing algorithms in hemodialysis patients

被引：0
|
作者：
Meaney, Calvin [1 ]
Gaesser, Jamie [2 ]
Robinson, Ben [2 ]
Krzyzanski, Wojciech [2 ]
Panesar, Mandip [3 ]
Rao, Gauri [4 ]
机构：
[1] SUNY Buffalo, Dept Pharm Practice, Sch Pharm & Pharmaceut Sci, Buffalo, NY USA
[2] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Buffalo, NY USA
[3] Erie Cty Med Ctr & Labs, Buffalo, NY USA
[4] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Experiential Educ, Chapel Hill, NC USA
来源：
PHARMACOTHERAPY | 2017年 / 37卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
537
引用
收藏
页码：E235 / E236
页数：2
相关论文
共 50 条
  • [1] Examining the Magnitude of Erythropoiesis-Stimulating Agent Hyporesponsiveness in Hemodialysis Patients
    Weinhandl, Eric D.
    Hwang, Yunji
    Gilbertson, David T.
    Petersen, Jeffrey
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 247 - 247
  • [2] Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
    Marit M Suttorp
    Tiny Hoekstra
    Joris I Rotmans
    Ilka Ott
    Moshe Mittelman
    Raymond T Krediet
    Friedo W Dekker
    BMC Nephrology, 14
  • [3] Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
    Suttorp, Marit M.
    Hoekstra, Tiny
    Rotmans, Joris I.
    Ott, Ilka
    Mittelman, Moshe
    Krediet, Raymond T.
    Dekker, Friedo W.
    BMC NEPHROLOGY, 2013, 14
  • [4] Erythropoiesis-stimulating agent withdrawal and oxidative stress in hemodialysis
    Monostori, P.
    Hracsko, Z.
    Karg, E.
    Varga, I. S.
    Kiss, Z.
    Boros, T.
    Kiss, E.
    Haszon, I.
    Papp, F.
    Suemegi, V.
    Bereczki, C.
    Turi, S.
    CLINICAL NEPHROLOGY, 2009, 71 (05) : 521 - 526
  • [5] Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients
    Luo, Jiacong
    Jensen, Donna E.
    Maroni, Bradley J.
    Brunelli, Steven M.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 68 (05) : 763 - 771
  • [6] Impact of iron and erythropoiesis-stimulating agent dose on mortality of hemodialysis patients with cancer
    Michon-Colin, Arthur
    Lombardi, Yannis
    Seret, Guillaume
    Lavainne, Frederic
    Testa, Angelo
    Rostoker, Guy
    Urena, Pablo
    Touzot, Maxime
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I148 - I148
  • [7] Impact of iron and erythropoiesis-stimulating agent dose on mortality of hemodialysis patients with cancer
    Michon-Colin, Arthur
    Lombardi, Yannis
    Seret, Guillaume
    Lavainne, Frederic
    Testa, Angelo
    Rostoker, Guy
    Urena, Pablo
    Touzot, Maxime
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [8] Relationship Between Erythropoiesis-Stimulating Agent Usage and Hemoglobin Variability in Hemodialysis Patients
    Tonbul, H. Zeki
    Altintepe, Lutfullah
    Baloglu, Ismail
    TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2018, 27 (01): : 63 - 67
  • [9] Definition and Validation of a Novel Metric of Erythropoiesis-Stimulating Agent Response in Hemodialysis Patients
    Meaney, Calvin J.
    Karas, Spinel
    Robinson, Ben
    Gaesser, Jamie
    Forrest, Alan
    Krzyzanski, Wojciech
    Panesar, Mandip
    Rao, Gauri G.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (03): : 418 - 426
  • [10] Comparative Effectiveness of Iron and Erythropoiesis-Stimulating Agent Dosing on Health-Related Quality of Life in Patients Receiving Hemodialysis
    Freburger, Janet K.
    Ellis, Alan R.
    Wang, Lily
    Butler, Anne M.
    Kshirsagar, Abhijit V.
    Winkelmayer, Wolfgang C.
    Brookhart, M. Alan
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2016, 67 (02) : 271 - 282
12345